Complementary and alternative medicine use in lung cancer patients in eight European countries.
about
The Peter Brojde lung cancer centre: a model of integrative practice.Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.Lung cancer survival with herbal medicine and vitamins in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey.The use of complementary and alternative medicine products in preceding two days among Finnish parents - a population surveyGreen tea and lung cancer: a systematic review.Use of Chinese medicine by cancer patients: a review of surveys.Reported effects of non-traditional treatments and complementary and alternative medicine by retinitis pigmentosa patients.Determination of parameters affecting the use of complementary and alternative medicine in cancer patients and detection of prevalence of use.An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.An assessment of the impact of herb-drug combinations used by cancer patients.The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study.Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.Differences between older and younger cancer survivors in seeking cancer information and using complementary/alternative medicine.Nutrition aspects of lung cancer.Great expectations: what do patients using complementary and alternative medicine hope for?Homeopathic drug discovery: theory update and methodological aspect.What attitudes and needs do citizens in Europe have in relation to complementary and alternative medicine?Induction of apoptosis in A431 skin cancer cells by Cissus quadrangularis Linn stem extract by altering Bax-Bcl-2 ratio, release of cytochrome c from mitochondria and PARP cleavage.Complementary and alternative medicine use among patients with thoracic malignancies.Dietary supplement use among cancer survivors of the NutriNet-Santé cohort study.Prevalence and Correlates of Complementary and Alternative Medicine Use among Patients with Lung Cancer: A Cross-Sectional Study in Beirut, Lebanon.Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.Prognostic proof and possible therapeutic mechanisms of herbal medicine in patients with metastatic lung and colon cancer.The effect of complementary and alternative medicine on quality of life, depression, anxiety, and fatigue levels among cancer patients during active oncology treatment: phase II study.Compensation scheme for complementary and alternative medicine use in asbestos-related diseases in New South Wales, Australia.Antioxidant properties of selected salak (Salacca zalacca) varieties in Sabah, Malaysia
P2860
Q30417605-679D7BD6-FAAE-4E46-B391-1D6E75B78E00Q33733423-D216BBDD-21F1-427D-953E-7AED91504861Q33985493-C37F2E51-66E3-44A6-BAD3-995408EB5CBAQ33992482-70846891-EC61-40EE-B392-065BF4BA7030Q34067274-2D218CEC-0764-47AB-9E3C-0B71E1EFF84AQ34270754-3E2C1D8C-C007-4DF4-9833-A85D23FF293AQ35141095-1F92BA6D-ED75-4BFA-9C75-E63138CE2875Q35163771-D78BBA4B-B636-405D-908D-48043FF9474EQ35556664-8D0ED974-48DF-4128-85D3-2199045E14A6Q35957933-9A4F9F49-A16A-4CC3-BBDB-39314EF42890Q36166875-FFAFD1E0-05D6-4A44-978F-498C3DF7E406Q36897753-18061E6D-9933-4088-BD4B-46281ACA6D18Q37117942-87988C0F-9EDE-4FF9-ABB1-E6403031E31BQ37388781-E14AF837-29C4-4F93-90A6-A347F74C36A2Q37643139-4D701D6C-BCF1-4381-BC73-C860AD38FCC9Q37902208-C7D526DF-2F68-43C1-AD8F-9AEAE538D17FQ38088805-F157F4E6-D607-49C8-8034-AD539808C4F2Q38123930-F12B30B0-F069-4098-8F60-DFC25B7FC884Q39240468-1F94BD7B-2DB3-42A3-8FA0-3702071C5906Q39247736-DE5FF5EB-6F62-4EAA-A896-333CD9FC627BQ41135449-519BD7A3-6B39-4CA0-8F46-E1A1F9D53D15Q41620561-0BBDB2EC-CF73-4634-86A8-449C7D46EB25Q42158376-65E1A130-7D5B-4660-9508-AADFA4780CBAQ47263035-985A37FB-1DD5-4CE2-89A4-122A50FE70BEQ47771547-B558A787-F5EF-47E3-A1C4-CA9DC5DC000EQ48552646-B4FD038A-E061-4618-9CD7-FB80FDF3C793Q59238821-5B0D6BA5-62A1-4DE3-9373-722DE9E2E082
P2860
Complementary and alternative medicine use in lung cancer patients in eight European countries.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Complementary and alternative ...... s in eight European countries.
@en
Complementary and alternative ...... s in eight European countries.
@nl
type
label
Complementary and alternative ...... s in eight European countries.
@en
Complementary and alternative ...... s in eight European countries.
@nl
prefLabel
Complementary and alternative ...... s in eight European countries.
@en
Complementary and alternative ...... s in eight European countries.
@nl
P2093
P1476
Complementary and alternative ...... s in eight European countries.
@en
P2093
Anita Margulies
Elin Madsen
Elisabeth Patiraki
Gulten Ozden
Maria Browall
Nurgun Platin
Paz Fernandez-Ortega
Vassiliki Panteli
P356
10.1016/J.CTCP.2005.09.007
P577
2005-11-14T00:00:00Z